Yousif Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.08M Buy
20,942
+1,993
+11% +$413K 0.05% 373
2026
Q1
$4.25M Sell
18,949
-351
-2% -$87.5K 0.05% 341
2025
Q4
$4.89M Sell
19,300
-1,518
-7% -$388K 0.05% 320
2025
Q3
$5.7M Sell
20,818
-1,179
-5% -$322K 0.06% 288
2025
Q2
$5.68M Sell
21,997
-485
-2% -$116K 0.06% 282
2025
Q1
$5.03M Buy
22,482
+101
+0.5% +$23.6K 0.06% 314
2024
Q4
$5.12M Buy
22,381
+693
+3% +$167K 0.06% 314
2024
Q3
$5.29M Sell
21,688
-169
-0.8% -$37.8K 0.06% 320
2024
Q2
$4.18M Sell
21,857
-650
-3% -$132K 0.05% 383
2024
Q1
$4.46M Sell
22,507
-158
-0.7% -$29K 0.05% 393
2023
Q4
$3.9M Sell
22,665
-706
-3% -$108K 0.05% 422
2023
Q3
$3.46M Sell
23,371
-427
-2% -$77.2K 0.04% 452
2023
Q2
$5.2M Buy
23,798
+748
+3% +$167K 0.06% 306
2023
Q1
$5.05M Sell
23,050
-186
-0.8% -$40.4K 0.07% 303
2022
Q4
$4.84M Buy
23,236
+1,552
+7% +$341K 0.06% 313
2022
Q3
$4.73M Sell
21,684
-70
-0.3% -$15.9K 0.07% 295
2022
Q2
$4.56M Sell
21,754
-250
-1% -$53.2K 0.06% 321
2022
Q1
$5.34M Buy
22,004
+64
+0.3% +$15.5K 0.06% 328
2021
Q4
$5.71M Buy
+21,940
New +$5.69M 0.06% 327

Other funds holding RMD

Yousif Capital Management's RMD Position: Q2 2026 in Review

Yousif Capital Management increased its ResMed (RMD) stake by 11% in Q2 2026, buying an estimated $413K and bringing the position to 20,942 shares worth $4.08M. The position accounts for 0.05% of the portfolio, ranked #373.

Yousif Capital Management first reported a position in RMD in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.71M in Q4 2021. 196 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Yousif Capital Management held 20,942 shares of ResMed worth $4.08M as of Q2 2026.
  • Yousif Capital Management bought 1,993 ResMed shares in Q2 2026, an estimated $413K.
  • ResMed made up 0.05% of Yousif Capital Management's portfolio in Q2 2026, its #373 holding.
  • Yousif Capital Management first reported a position in ResMed in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's ResMed position peaked at $5.71M in Q4 2021.
  • 196 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.